Subtype-Independent ANP32E Reduction During Breast Cancer Progression in Accordance with Chromatin Relaxation.

Autor: Ruff GL; Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, 14642, USA., Murphy KE; Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, 14642, USA., Smith ZR; Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, 14642, USA.; Wilmot Cancer Institute, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14624, USA., Vertino PM; Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, 14642, USA.; Wilmot Cancer Institute, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14624, USA., Murphy PJ; Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, 14642, USA. Patrick_Murphy@URMC.Rochester.edu.; Wilmot Cancer Institute, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14624, USA. Patrick_Murphy@URMC.Rochester.edu.
Jazyk: angličtina
Zdroj: BMC cancer [BMC Cancer] 2021 Dec 18; Vol. 21 (1), pp. 1342. Date of Electronic Publication: 2021 Dec 18.
DOI: 10.1186/s12885-021-09077-9
Abstrakt: Background: Chromatin state provides a clear decipherable blueprint for maintenance of transcriptional patterns, exemplifying a mitotically stable form of cellular programming in dividing cells. In this regard, genomic studies of chromatin states within cancerous tissues have the potential to uncover novel aspects of tumor biology and unique mechanisms associated with disease phenotypes and outcomes. The degree to which chromatin state differences occur in accordance with breast cancer features has not been established.
Methods: We applied a series of unsupervised computational methods to identify chromatin and molecular differences associated with discrete physiologies across human breast cancer tumors.
Results: Chromatin patterns alone are capable of stratifying tumors in association with cancer subtype and disease progression. Major differences occur at DNA motifs for the transcription factor FOXA1, in hormone receptor-positive tumors, and motifs for SOX9 in Basal-like tumors. We find that one potential driver of this effect, the histone chaperone ANP32E, is inversely correlated with tumor progression and relaxation of chromatin at FOXA1 binding sites. Tumors with high levels of ANP32E exhibit an immune response and proliferative gene expression signature, whereas tumors with low ANP32E levels appear programmed for differentiation.
Conclusions: Our results indicate that ANP32E may function through chromatin state regulation to control breast cancer differentiation and tumor plasticity. This study sets a precedent for future computational studies of chromatin changes in carcinogenesis.
(© 2021. The Author(s).)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje